Monitoring oncogenic B-RAF-induced senescence in melanocytes

Sieu L Tran1, Helen Rizos

  • 1Melanoma Institute Australia, North Sydney, Australia.

Insights

The B-RAF(V600E) mutation, common in melanoma, causes cell cycle arrest resembling senescence in healthy cells. This study analyzes this B-RAF-induced senescence in human melanocytes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The B-RAF kinase, a RAS pathway effector, is frequently activated in human melanomas.
  • The oncogenic B-RAF(V600E) mutation drives melanoma development by cooperating with other genetic changes.
  • In primary cells, B-RAF(V600E) induces a cell cycle arrest mimicking cellular senescence.

Purpose of the Study:

  • To investigate the mechanisms of B-RAF-induced senescence in primary human melanocytes.
  • To analyze the cellular response to the common B-RAF(V600E) mutation in a relevant cell type.

Main Methods:

  • Utilized recombinant lentiviruses for gene delivery.
  • Studied primary human melanocytes.
  • Analyzed B-RAF-induced senescence phenotypes.

Main Results:

  • B-RAF(V600E) expression in primary human melanocytes triggers a senescence-like cell cycle arrest.
  • This senescence is a significant barrier to transformation by B-RAF(V600E) in non-immortalized cells.

Conclusions:

  • Cellular senescence is a critical tumor-suppressive mechanism activated by oncogenic B-RAF in normal melanocytes.
  • Understanding B-RAF-induced senescence is crucial for developing effective melanoma therapies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...